Syringes and Needles Market to Grow at 6.73% CAGR Through 2030, Driven by Rising Vaccination Programs and Chronic Disease Burden | DelveInsight

The global syringes and needles market is set to witness steady growth, driven by the increasing prevalence of infectious diseases, expanding vaccination programs, and advancements in safety-focused product designs. Key players include Becton, Dickinson and Company, B. Braun SE, Terumo Medical Corporation, Gerresheimer AG, ICU Medical, Inc., Cardinal Health, Hindustan Syringes & Medical Devices Ltd., Nipro Medical Corporation, and Schott Pharma, among others.
According to DelveInsight's comprehensive report titled "Syringes and Needles: Market Insights, Competitive Landscape, and Market Forecast - 2030 [https://www.delveinsight.com/report-store/syringes-and-needles-market?utm_source=report&utm_medium=promotion&utm_campaign=xpr]", the syringes and needles market is expected to expand at a CAGR of 6.73% during the forecast period from 2024 to 2030. This growth is primarily driven by the increasing incidence of infectious diseases globally, rising demand for vaccination programs, and advancements in product safety designs.

North America currently dominates the syringes and needles market, holding the largest revenue share in 2023. This dominance is attributed to high rates of diabetes (affecting 11.3% of the U.S. population) and cardiovascular diseases (with 20 million U.S. adults suffering from coronary artery disease). North America's leadership is further supported by significant investments in research and development, as well as favorable regulatory pathways for advanced drug delivery systems.

Unlock in-depth insights into the global syringes and needles market landscape @ Syringes and Needles Market Insights [https://www.delveinsight.com/sample-request/syringes-and-needles-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr].

Globally, the syringes and needles market is significantly impacted by the alarming rise in infectious diseases. In 2020, approximately 38 million people were living with HIV, necessitating the use of syringes and needles for blood collection and diagnostic purposes. Additionally, lifestyle-related disorders, particularly diabetes, have created substantial demand for insulin syringes and needle-free injections. As of 2021, around 540 million adults (1 in 10) were living with diabetes, with projections indicating an increase to 640 million by 2030 and 780 million by 2045.

Another significant driver of the syringes and needles market is the growing need for vaccination programs worldwide. The mass immunization efforts, especially following the COVID-19 pandemic, have highlighted the crucial role of injection devices in public health infrastructure. Prefilled syringes have emerged as a preferred delivery method for biologics and vaccines, a trend expected to continue as governments and healthcare organizations prioritize preventive healthcare measures against various infectious diseases.

The report segmented the syringes and needles market by usage, type, end-user, and geography. The market segmentation analysis reveals that disposable syringes dominate the usage segment due to infection control mandates. Additionally, pen needles are anticipated to capture a significant revenue share, owing to their convenience, reduced pain, and easier storage and transport for the growing diabetic population. Despite higher costs compared to traditional vial and syringe methods, the benefits of pen needles have made them increasingly popular among healthcare providers and patients.

The DelveInsight report further analyzes the competitive landscape, featuring both established medical technology giants and specialized manufacturers in the syringes and needles market. Key players include Becton, Dickinson and Company, B. Braun SE, Terumo Medical Corporation, Gerresheimer AG, ICU Medical, Inc., Cardinal Health, Hindustan Syringes & Medical Devices Ltd., Nipro Medical Corporation, and Schott Pharma, among others. These companies are actively engaged in product development and innovation, reshaping the medical needles and syringes competitive landscape.

Discover the key factors fueling market growth - from rising chronic diseases to innovation in injection safety @ Syringes and Needles Market Drivers [https://www.delveinsight.com/sample-request/syringes-and-needles-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr].

Recent regulatory milestones and commercial developments highlight the market's evolution toward specialized applications. Furthermore, advancements such as retractable needles, shielding mechanisms, and prefilled syringes are becoming more popular, enhancing safety and reducing needlestick injuries among healthcare workers. In March 2025, ANI Pharmaceuticals (NASDAQ: ANIP) announced the FDA approval and launch of Purified Cortrophin Gel in a prefilled syringe format. This innovation simplifies administration for patients.

Efforts to minimize reliance on single-use plastics have led to innovations in syringe designs using eco-friendly materials, addressing environmental concerns associated with medical waste. For instance, RAUMEDIC's Green Syringe incorporates biopolymers and thermoplastic elastomers to reduce the carbon footprint by 71% while maintaining regulatory compliance and functionality. These innovations address critical barriers in the needles and syringes market related to safety concerns and bio-waste.

Stay ahead with the latest breakthroughs, FDA approvals, and eco-friendly innovations shaping the future of syringes and needles. Visit Syringes and Needles Recent Developments. [https://www.delveinsight.com/sample-request/syringes-and-needles-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]

While growth prospects remain strong, the syringes and needles market faces challenges, including pricing pressures in emerging economies and environmental concerns about plastic waste. Manufacturers are addressing these barriers through sustainable material innovations and partnerships with recycling initiatives. The competitive landscape is further intensified by regional players offering cost-competitive alternatives, necessitating continuous product differentiation through safety features and usability enhancements.

Table of Contents

1.

Syringes and Needles Market Report Introduction

2.

Syringes and Needles Market Executive Summary

3.

Regulatory Analysis

4.

Syringes and Needles Market Key Factors Analysis

5.

Syringes and Needles Market Porter's Five Forces Analysis

6.

Syringes and Needles Market Layout

7.

Syringes and Needles Market Company and Product Profiles

8.

KOL Views

9.

Project Approach

10.

About DelveInsight

11.

Disclaimer & Contact Us

Related Reports

Prefilled Syringes Market Insights [https://www.delveinsight.com/sample-request/prefilled-syringes-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]

The Prefilled Syringes Market Insights report provides a comprehensive analysis of the global prefilled syringes market, including market size, share, growth trends, key drivers, and forecasts. The report also highlights regional market dynamics, competitive landscapes, technological advancements, and strategic initiatives by leading companies such as BD (NASDAQ: BDX), NIPRO Pharma, Taisei Kako Co. Ltd, TERUMO PHARMACEUTICAL SOLUTIONS., SCHOTT AG, Gerresheimer AG, West Pharmaceutical Services (NASDAQ: WST), Inc., Dali Medical Devices, Stevanato Group (NASDAQ: STVN), Credence MedSystems, Inc., Baxter, MAEDA INDUSTRY Co., Ltd., MedXL Inc, IRISYS, LLC, Sandoz International GmbH, Pfizer Inc., Vetter, Weigao Group, Fresenius Kabi, Catalent Inc (NASDAQ: CTLT) and others

About DelveInsight

DelveInsight is a leading market research and consulting firm specializing in disease-specific insights and therapeutic market analysis. Their reports integrate real-world data, clinical trial findings, and expert interviews to deliver comprehensive industry intelligence.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Arpit Anand
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=syringes-and-needles-market-to-grow-at-673-cagr-through-2030-driven-by-rising-vaccination-programs-and-chronic-disease-burden-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.